Treatments for gynaecological cancers

Sean Kehoe

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)


Gynaecological cancers account for a significant amount of morbidity and mortality in the world, with varying incidences and outcomes depending on the country. These malignancies consist of vulval, vaginal, cervical, endometrial, fallopian and ovarian cancers, and account for between 10 and 15% of women's cancers. Although mainly a disease of post-menopausal women, when affecting younger women, fertility-related consequences exist. Therapeutic interventions for gynaecological cancers include surgery, chemotherapy and radiotherapy, with combination modalities often required. The basis for certain therapies are derived from appropriately conducted randomized clinical trial, whereas in some settings, therapy is based on clinical experience and intuition. This review will endeavour to focus on the evidence base, though inevitably, non-evidence based practice is unavoidable.
Original languageEnglish
Pages (from-to)985-1000
Number of pages16
JournalBest Practice & Research: Clinical Obstetrics & Gynaecology
Issue number6
Publication statusPublished - 2006


  • Treatment
  • gynaecological
  • Cancers


Dive into the research topics of 'Treatments for gynaecological cancers'. Together they form a unique fingerprint.

Cite this